Anti-inflammatory and Analgesic Activities of Mature Fresh Leaves of Vitex Negundo
Overview
Affiliations
This study confirmed the oral anti-inflammatory, analgesic and antihistamine properties of mature fresh leaves (MFL) of Vitex negundo L. (Verbenaceae) claimed in the Ayurveda medicine by orally treating a water extract of the leaves to rats. The early phase (2h) of carrageenan-induced rat paw oedema was significantly (P<0.01) suppressed in an inversely does-dependent (r(2)=1, P<0.01) manner by MFL. The EC(50) was 2g/kg of MFL. In the formaldehyde-induced rat paw oedema test, the 2.5 and 5g/kg leaves significantly (P<0.05) suppressed the inflammation on days 4-6 of the test. In the hot plate test, 2.5 and 5g/kg of MFL showed a significant (P<0.05) and directly dose-dependent analgesic activity at 1h of treatment while the activity was absent in the tail flick test in rats. The EC(50) for the analgesic activity was 4.1g/kg. In the formalin test, 1.25, 2.5 and 5g/kg of MFL significantly (P<0.05) suppressed the pain in both the phases of the test like aspirin. The leaves showed an inversely dose-dependent in vivo antihistamine and in vitro prostaglandin (PG) synthesis inhibition, membrane stabilising and antioxidant activities. Naloxone did not abolish the analgesic activity in the hot plate test. A 5g/kg of MFL did not impair muscle strength and co-ordination and did not induce sedation. The treatment of 5g/kg of MFL did not show signs of acute toxicity or stress. Fourteen-day oral treatment of 5g/kg of MFL significantly increased the serum activity of AST. Flowering of the tree did not abolish the analgesic and anti-inflammatory activities of the leaves. These observations revealed that the fresh leaves of Vitex negundo have anti-inflammatory and pain suppressing activities possibly mediated via PG synthesis inhibition, antihistamine, membrane stabilising and antioxidant activities. The antihistamine activity can produce the anti-itching effect claimed in Ayurveda medicine.
Kalman D, Srivastava S, Desale A, Chatte M, Nalavade R, Shah K Drug Des Devel Ther. 2025; 19:811-825.
PMID: 39931217 PMC: 11809229. DOI: 10.2147/DDDT.S486836.
Mittal V, Sharma A Recent Adv Inflamm Allergy Drug Discov. 2024; 18(2):90-107.
PMID: 39404108 DOI: 10.2174/0127722708292961240508110207.
Khan F, Swarnkar C, Soni L, Sharma S J Parasit Dis. 2024; 48(2):257-268.
PMID: 38840874 PMC: 11147997. DOI: 10.1007/s12639-024-01660-8.
Kim H, Hong J Int J Mol Sci. 2024; 25(10).
PMID: 38791435 PMC: 11121510. DOI: 10.3390/ijms25105397.
Srivastava S, Girandola R J Pain Res. 2023; 16:2141-2153.
PMID: 37384126 PMC: 10295599. DOI: 10.2147/JPR.S412018.